DCN Dx Acquires Biomed Diagnostics
April 25, 2022
DCN Dx has completed its acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, Oregon. The deal expands DCN Dx's point-of-use testing and sampling capabilities across human, veterinary, food safety and environmental markets by adding Biomed's InPouch/InTray culture and transport product lines.
- Buyers
- DCN Dx
- Targets
- Biomed Diagnostics, Inc.
- Industry
- Medical Devices
- Location
- Oregon, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
DCN Dx Acquires PortaScience
June 17, 2021
Medical Devices
DCN Dx, a Carlsbad, California-based developer of point-of-care diagnostics, has completed the acquisition of PortaScience, Inc., a dry-chemistry focused point-of-care diagnostics development company based in Moorestown, New Jersey. The deal adds PortaScience's PortaCheck animal-health product line and expands DCN Dx's assay development, engineering, and product portfolio for healthcare, veterinary, and consumer diagnostics.
-
Becton Dickinson Acquires NAT Diagnostics
May 15, 2020
Medical Devices
Becton Dickinson (BD) has acquired NAT Diagnostics, a molecular diagnostics firm that developed an isothermal NAT Dx technology for rapid point-of-care testing. BD plans to further develop the NAT Dx platform to offer decentralized molecular testing options targeted for early 2023, expanding BD’s capabilities in point-of-care molecular diagnostics.
-
Martis Capital Invests in DCN Dx
November 19, 2020
Medical Devices
Martis Capital has made a growth equity investment in DCN Dx, a Carlsbad, California-based lateral flow diagnostics developer and contract developer of rapid point-of-care tests. As part of the transaction, Charlie Mamrak will join DCN Dx as CEO; the capital will be used to accelerate growth and expand the company's diagnostic capabilities. Financial terms were not disclosed and Pegasus Capital and TM Capital advised on the deal.
-
Matrix Medical Network Acquires Biocerna
October 2, 2020
Healthcare Services
Matrix Medical Network acquired Biocerna, a CLIA-certified and CAP-accredited clinical laboratory based in Fulton, Maryland, to integrate in-house diagnostic and COVID-19 testing capabilities. The acquisition expands Matrix's ability to deliver timely testing services to its network of clinicians and mobile health clinics, supporting employer testing, clinical trial support, and other client-facing diagnostic services.
-
ICON plc Acquires MolecularMD Corporation
February 21, 2019
Healthcare Services
ICON plc acquired MolecularMD Corporation, a molecular diagnostic specialty laboratory, to expand ICON's molecular diagnostic testing capabilities—including next-generation sequencing and immunohistochemistry—and strengthen support for oncology drug–diagnostic co-development. The acquisition integrates MolecularMD's central laboratory services and client base into ICON's global laboratory network to support precision medicine programs across clinical development phases.
-
RDi (LDC-backed) Acquires MedDX and Shuttlepac
October 23, 2023
Healthcare Services
LDC-backed RDi has acquired diagnostic sample collection and transport packaging provider MedDX and biological sample packaging specialist Shuttlepac. The add-on purchases broaden RDi’s healthcare kitting and component capabilities, increase supply-chain control and position the business for planned expansion into the United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.